{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:57:39Z","timestamp":1785412659445,"version":"3.56.0"},"reference-count":102,"publisher":"Oxford University Press (OUP)","issue":"1053","license":[{"start":{"date-parts":[[2013,3,22]],"date-time":"2013-03-22T00:00:00Z","timestamp":1363910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Restless legs syndrome (RLS) is a common sensory motor neurological disorder that is characterised by an irresistible urge to move the legs that significantly affects the quality of life of the patient. Prevalence in the general population is 5\u201325% and it is twice as prevalent in women as in men. RLS is the most common movement disorder in pregnancy with a fourfold increased risk of developing this disorder later in life. The pathophysiology of RLS is centred on dopaminergic dysfunction, reduced central nervous system iron, genetic linkages, or alteration in neurotransmitters such as hypocretins, endorphins levels and immune dysfunction and inflammatory mechanisms. With the emergence of new evidence, there are changes to the previous treatment recommendations for RLS. There is sufficient evidence to conclude that dopamine agonists such as rotigotine transdermal patch, pramipexole, ropinirole, gabapentin enacarbil, pregabalin and gabapentin are effective in the short-term treatment of RLS and rotigotine, followed by gabapentin enacarbil, ropinirole, pramipexole and gabapentin for long-term treatment. Based on expert consensus, the recommendation for daily RLS is dopamine agonists or gabapentin or low-potency opioids. Levodopa is less preferred for treating daily RLS due to its high risk of augmentation. For intermittent RLS, it is levodopa or dopamine agonists or low-potency opioids or benzodiazepines. For refractory RLS, the choice is to change to gabapentin or a different dopamine agonist, addition of a second agent like gabapentin or benzodiazepine to the existing drug or changing to a high-potency opioid or tramadol. Medications with safety record in pregnancy include opioids and antiepileptics such as carbamazepine and gabapentin. There are concerns that patients with RLS are at risk for metabolic deregulation, autonomic dysfunction and cardiovascular morbidity. However, a recent study concluded that RLS is not associated with increased risk of cardiovascular complications.<\/jats:p>","DOI":"10.1136\/postgradmedj-2012-131634","type":"journal-article","created":{"date-parts":[[2013,3,23]],"date-time":"2013-03-23T02:34:12Z","timestamp":1364006052000},"page":"402-410","source":"Crossref","is-referenced-by-count":58,"title":["Restless legs syndrome: pathophysiology and modern management"],"prefix":"10.1093","volume":"89","author":[{"given":"Kavitha","family":"Nagandla","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Melaka Manipal Medical College , Melaka, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somsubhra","family":"De","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Melaka Manipal Medical College , Melaka, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,3,22]]},"reference":[{"key":"2023041906225982500_bib1","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/j.1468-1331.2012.03853.x","article-title":"European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society","volume":"11","author":"Garcia-Borreguero","year":"2012","journal-title":"Eur J Neurol"},{"issue":"Suppl 18","key":"2023041906225982500_bib2","doi-asserted-by":"crossref","first-page":"S401","DOI":"10.1002\/mds.21604","article-title":"Definition of restless legs syndrome, how to diagnose it, and how to differentiate it from RLS mimics","volume":"22","author":"Benes","year":"2007","journal-title":"Mov Disord"},{"key":"2023041906225982500_bib3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2377-11-28","article-title":"Algorithms for the diagnosis and treatment of restless legs syndrome in primary care","volume":"11","author":"Garcia-Borreguero","year":"2011","journal-title":"BMC Neurology"},{"key":"2023041906225982500_bib4","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1212\/01.WNL.0000163996.64461.A3","article-title":"Restless legs syndrome: a community-based study of prevalence, severity, and risk factors","volume":"64","author":"H\u00f6gl","year":"2005","journal-title":"Neurology"},{"key":"2023041906225982500_bib5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/mds.23430","article-title":"Prevalence and disease burden of primary restless legs syndrome: results of a general population survey in the United States","volume":"26","author":"Allen","year":"2011","journal-title":"Mov Disord"},{"key":"2023041906225982500_bib6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.sleep.2004.03.006","article-title":"Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study","volume":"5","author":"Hening","year":"2004","journal-title":"Sleep Med"},{"key":"2023041906225982500_bib7","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1007\/s00415-004-0552-7","article-title":"Analysis of familial and sporadic restless legs syndrome in age of onset, gender, and severity features","volume":"251","author":"Hanson","year":"2004","journal-title":"J Neurol"},{"key":"2023041906225982500_bib8","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/archinte.165.11.1286","article-title":"Restless legs syndrome prevalence and impact: REST general population study","volume":"165","author":"Allen","year":"2005","journal-title":"Arch Intern Med"},{"key":"2023041906225982500_bib9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/mds.1102","article-title":"Restless legs syndrome in an Asian population: a study in Singapore","volume":"16","author":"Tan","year":"2001","journal-title":"Mov Disord"},{"key":"2023041906225982500_bib10","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1440-1819.2005.01381.x","article-title":"Prevalence of restless legs syndrome and associated factors in the Korean adult population: the Korean Health and Genome Study","volume":"59","author":"Kim","year":"2005","journal-title":"Psychiatry Clin Neurosci"},{"key":"2023041906225982500_bib11","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1046\/j.1440-1819.2000.00685.x","article-title":"Prevalence of periodic limb movement-like and restless legs-like symptoms among Japanese adults","volume":"54","author":"Kageyama","year":"2000","journal-title":"Psychiatry Clin Neurosci"},{"key":"2023041906225982500_bib12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.sleep.2006.11.004","article-title":"Restless legs syndrome in an Indian urban population","volume":"9","author":"Rangarajan","year":"2007","journal-title":"Sleep Med"},{"key":"2023041906225982500_bib13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4414\/sanp.2003.01413","article-title":"Restless legs syndrome: pathophysiology and clinical aspects","volume":"154","author":"Sforza","year":"2003","journal-title":"Schweiz Arch Neurol Psychiatr"},{"key":"2023041906225982500_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.sleep.2007.11.002","article-title":"Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson's disease","volume":"10","author":"Poceta","year":"2009","journal-title":"Sleep Med"},{"key":"2023041906225982500_bib15","first-page":"1200","article-title":"Assessment of restless legs syndrome\u2014methodological approaches for use in practice and clinical trials","volume":"8","author":"Kohnen","year":"2008","journal-title":"Mov Disord"},{"key":"2023041906225982500_bib16","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.5665\/sleep.1986","article-title":"The treatment of restless legs syndrome and periodic limb movement disorder in adults\u2014an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses","volume":"35","author":"Aurora","year":"2012","journal-title":"SLEEP"},{"key":"2023041906225982500_bib17","first-page":"533","article-title":"Diagnosis and symptom rating scale of restless legs syndrome","volume":"5","author":"Inoue","year":"2009","journal-title":"Brain Nerve"},{"key":"2023041906225982500_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1389-9457(03)00010-8","article-title":"Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health","volume":"4","author":"Allen","year":"2003","journal-title":"Sleep Med"},{"key":"2023041906225982500_bib19","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/sleep\/28.7.843","article-title":"Circadian variation of the effects of immobility on symptoms of restless legs syndrome","volume":"7","author":"Michaud","year":"2005","journal-title":"Sleep"},{"key":"2023041906225982500_bib20","first-page":"235","article-title":"Restless legs syndrome","volume":"78","author":"Bayard","year":"2008","journal-title":"Am Fam Physician"},{"key":"2023041906225982500_bib21","first-page":"539","article-title":"Secondary restless legs syndrome","volume":"61","author":"Oka","year":"2009","journal-title":"Brain Nerve"},{"key":"2023041906225982500_bib22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mds.870120111","article-title":"Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria","volume":"12","author":"Montplaisir","year":"1997","journal-title":"Mov Disord"},{"key":"2023041906225982500_bib23","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/WNL.55.9.1404","article-title":"Restless legs syndrome in monozygotic twins: clinical correlates","volume":"55","author":"Ondo","year":"2000","journal-title":"Neurology"},{"key":"2023041906225982500_bib24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1399-0004.2007.00937.x","article-title":"Restless legs syndrome: an update on genetics and future perspectives","volume":"73","author":"Pichler","year":"2008","journal-title":"Clin Genet"},{"key":"2023041906225982500_bib25","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3724\/SP.J.1005.2009.00675","article-title":"Advances in genetics of restless legs syndrome","volume":"31","author":"Fan","year":"2009","journal-title":"Yi Chuan"},{"key":"2023041906225982500_bib26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00415-009-0134-9","article-title":"Recent advances in the diagnosis, genetics and treatment of restless legs syndrome","volume":"256","author":"Trenkwalder","year":"2009","journal-title":"J Neurol"},{"key":"2023041906225982500_bib27","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.sleep.2011.06.006","article-title":"Association studies of variants in MEIS1, BTBD9, and MAP2K5\/SKOR1 with restless legs syndrome in a US population","volume":"12","author":"Yang","year":"2011","journal-title":"Sleep Med"},{"key":"2023041906225982500_bib28","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/jmg.2010.087858","article-title":"MEIS1 and BTBD9: genetic association with restless leg syndrome in end stage renal disease","volume":"48","author":"Schormair","year":"2011","journal-title":"J Med Genet"},{"key":"2023041906225982500_bib29","volume-title":"RLS medical bulletin","author":"Rye","year":"2005"},{"key":"2023041906225982500_bib30","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1212\/WNL.52.5.944","article-title":"A randomized controlled study of pergolide in patients with restless legs syndrome","volume":"52","author":"Wetter","year":"1999","journal-title":"Neurology"},{"key":"2023041906225982500_bib31","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1212\/WNL.54.2.502","article-title":"An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome","volume":"54","author":"Ruottinen","year":"2000","journal-title":"Neurology"},{"key":"2023041906225982500_bib32","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1212\/WNL.52.5.932","article-title":"Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies","volume":"52","author":"Turjanski","year":"1999","journal-title":"Neurology"},{"key":"2023041906225982500_bib33","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/brain\/awl163","article-title":"Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding","volume":"129","author":"Cervenka","year":"2006","journal-title":"Brain"},{"key":"2023041906225982500_bib34","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1212\/WNL.57.7.1307","article-title":"Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome","volume":"57","author":"Eisensehr","year":"2001","journal-title":"Neurology"},{"key":"2023041906225982500_bib35","first-page":"409","volume-title":"Parkinson's disease and movement disorders","author":"Ondo","year":"2007","edition":"5th edn"},{"key":"2023041906225982500_bib36","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1474-4422(05)70139-3","article-title":"The restless legs syndrome","volume":"4","author":"Trenkwalder","year":"2005","journal-title":"Lancet Neurol"},{"key":"2023041906225982500_bib37","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/1097-4547(20001201)62:5<623::AID-JNR1>3.0.CO;2-H","article-title":"Insight into the pathophysiology of restless legs syndrome","volume":"62","author":"Earley","year":"2000","journal-title":"J Neurosci Res"},{"key":"2023041906225982500_bib38","doi-asserted-by":"crossref","first-page":"S440","DOI":"10.1002\/mds.21607","article-title":"The role of iron in restless legs syndrome","volume":"22","author":"Allen","year":"2007","journal-title":"Mov Disord"},{"key":"2023041906225982500_bib39","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/WNL.54.8.1698","article-title":"Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome","volume":"54","author":"Earley","year":"2000","journal-title":"Neurology"},{"key":"2023041906225982500_bib40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1212\/WNL.56.2.263","article-title":"MRI measurement of brain iron in patients with restless legs syndrome","volume":"56","author":"Allen","year":"2001","journal-title":"Neurology"},{"key":"2023041906225982500_bib41","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/smrv.2001.0156","article-title":"Iron, brain and restless legs syndrome","volume":"5","author":"Krieger","year":"2001","journal-title":"Sleep Med Rev"},{"key":"2023041906225982500_bib42","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.sleep.2004.03.002","article-title":"The treatment of restless legs syndrome with intravenous iron dextran","volume":"5","author":"Earley","year":"2004","journal-title":"Sleep Med"},{"key":"2023041906225982500_bib43","first-page":"643","article-title":"Suggestive evidence of erythropoietin level abnormality in patients with sporadic and familial cases of the restless legs syndrome","volume":"28","author":"Kemlink","year":"2007","journal-title":"Neuro endocrinology letters"},{"key":"2023041906225982500_bib44","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1389-9457(02)00108-9","article-title":"Race, iron status and restless legs syndrome","volume":"3","author":"Allen","year":"2002","journal-title":"Sleep Med"},{"key":"2023041906225982500_bib45","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.neuro.25.112701.142826","article-title":"The role of hypocretins (orexins) in sleep regulation and narcolepsy","volume":"25","author":"Taheri","year":"2002","journal-title":"Annu Rev Neurosci"},{"key":"2023041906225982500_bib46","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1212\/WNL.59.4.639","article-title":"Increased CSF hypocretin-1 (orexin-A) in restless legs syndrome","volume":"59","author":"Allen","year":"2002","journal-title":"Neurology"},{"key":"2023041906225982500_bib47","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1212\/01.WNL.0000094196.50155.38","article-title":"CSF hypocretin-1 levels in restless legs syndrome","volume":"10","author":"Stiasny-Kolster","year":"2003","journal-title":"WH Neurology"},{"key":"2023041906225982500_bib48","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.smrv.2011.09.003","article-title":"Restless legs syndrome\u2014theoretical roles of inflammatory and immune mechanisms","volume":"6","author":"Weinstock","year":"2012","journal-title":"Sleep Med Rev"},{"key":"2023041906225982500_bib49","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/sleep\/32.5.589","article-title":"Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke","volume":"32","author":"Walters","year":"2009","journal-title":"Sleep"},{"key":"2023041906225982500_bib50","doi-asserted-by":"crossref","first-page":"e000866","DOI":"10.1136\/bmjopen-2012-000866","article-title":"Restless legs syndrome and risk of incident cardiovascular disease in women and men: prospective cohort","volume":"2","author":"Winter","year":"2012","journal-title":"BMJ Open"},{"key":"2023041906225982500_bib51","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.sleep.2004.01.010","article-title":"Neurophysiological investigations in restless legs syndrome and other disorders of movement during sleep","volume":"4","author":"Ferreri","year":"2004","journal-title":"Sleep Med"},{"key":"2023041906225982500_bib52","doi-asserted-by":"crossref","first-page":"916","DOI":"10.4065\/79.7.916","article-title":"An algorithm for the management of restless legs syndrome","volume":"79","author":"Silber","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"2023041906225982500_bib53","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1212\/01.wnl.0000231513.23919.a1","article-title":"Efficacy and safety of pramipexole in restless legs syndrome","volume":"67","author":"Winkelman","year":"2006","journal-title":"Neurology"},{"key":"2023041906225982500_bib54","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/j.1468-1331.2006.01459.x","article-title":"Long-term treatment with pramipexole in restless legs syndrome","volume":"13","author":"Montplaisir","year":"2006","journal-title":"Eur J Neurol"},{"key":"2023041906225982500_bib55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4065\/81.1.17","article-title":"TREAT RLS US (Therapy with Ropinirole Efficacy and Tolerability in RLS US) Study Group. Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial","volume":"81","author":"Bogan","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"2023041906225982500_bib56","first-page":"92","article-title":"Ropinirole in the treatment of restless legs syndrome: Results from the TREAT RLS 1 study, a 12-week, randomised, placebo-controlled study in 10 European countries","volume":"75","author":"Trenkwalder","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2023041906225982500_bib57","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/mds.20257","article-title":"Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: A 12-week, double-blind, randomized, parallel-group, placebo-controlled study","volume":"19","author":"Walters","year":"2004","journal-title":"Mov Disord"},{"key":"2023041906225982500_bib58","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/sleep\/27.5.907","article-title":"Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome","volume":"27","author":"Allen","year":"2004","journal-title":"Sleep"},{"key":"2023041906225982500_bib59","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S1474-4422(06)70576-2","article-title":"Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome","volume":"5","author":"Paulus","year":"2006","journal-title":"Lancet Neurol"},{"key":"2023041906225982500_bib60","first-page":"473","volume-title":"Sleep: a comprehensive handbook","author":"Teofilo","year":"2006"},{"key":"2023041906225982500_bib61","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/mds.20983","article-title":"Controlled withdrawal of pramipexole after 6\u2005months of open-label treatment in patients with restless legs syndrome","volume":"21","author":"Trenkwalder","year":"2006","journal-title":"Mov Disord"},{"key":"2023041906225982500_bib62","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.sleep.2006.09.009","article-title":"A 52-week open label study of the long-term safety of ropinirole in patients with restless legs syndrome","volume":"8","author":"Garcia-Borreguero","year":"2007","journal-title":"Sleep Med"},{"key":"2023041906225982500_bib63","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S1474-4422(11)70127-2","article-title":"Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study","volume":"10","author":"Oertel","year":"2011","journal-title":"Lancet Neurol"},{"key":"2023041906225982500_bib64","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(04)15945-X","article-title":"Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease","volume":"363","author":"Van Camp","year":"2004","journal-title":"Lancet"},{"key":"2023041906225982500_bib65","first-page":"Issue 2. Art.: CD005504","article-title":"Levodopa for restless legs syndrome","author":"Scholz","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2023041906225982500_bib66","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/sleep\/19.3.205","article-title":"Augmentation of the restless legs syndrome with carbidopa\/levodopa","volume":"19","author":"Allen","year":"1996","journal-title":"Sleep"},{"key":"2023041906225982500_bib67","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/sleep\/19.10.801","article-title":"Pergolide and carbidopa\/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients","volume":"19","author":"Earley","year":"1996","journal-title":"Sleep"},{"key":"2023041906225982500_bib68","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00415-009-5299-8","article-title":"Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study","volume":"257","author":"Hogl","year":"2010","journal-title":"J Neurol"},{"key":"2023041906225982500_bib69","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0924-977X(01)00080-3","article-title":"Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) Acute placebo controlled sleep laboratory studies with clonazepam","volume":"11","author":"Saletu","year":"2001","journal-title":"Eur Neuropsychopharmacol"},{"key":"2023041906225982500_bib70","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/mds.1214","article-title":"Long-term follow-up on restless legs syndrome patients treated with opioids","volume":"16","author":"Walters","year":"2001","journal-title":"Mov Disord"},{"key":"2023041906225982500_bib71","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.sleep.2010.11.002","article-title":"A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome","volume":"5","author":"Silver","year":"2011","journal-title":"Sleep Med"},{"key":"2023041906225982500_bib72","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000072882","article-title":"The Treatment of restless legs syndrome: gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome","volume":"48","author":"Happe","year":"2003","journal-title":"Neuropsychobiology"},{"key":"2023041906225982500_bib73","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1212\/WNL.59.10.1573","article-title":"Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study","volume":"59","author":"Garcia-Borreguero","year":"2002","journal-title":"Neurology"},{"key":"2023041906225982500_bib74","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/sleep\/32.2.159","article-title":"A randomized, double-blind, placebo-controlled, crossover study of XP13512\/GSK1838262 in the treatment of patients with primary restless legs syndrome","volume":"32","author":"Kushida","year":"2009","journal-title":"Sleep"},{"key":"2023041906225982500_bib75","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/WNF.0b013e3181b3ab16","article-title":"Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trial","volume":"32","author":"Walters","year":"2009","journal-title":"Clin Neuropharmacol"},{"key":"2023041906225982500_bib76","doi-asserted-by":"crossref","first-page":"282","DOI":"10.5664\/JCSM.1074","article-title":"A randomized, double-blind,placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome","volume":"7","author":"Lee","year":"2011","journal-title":"J Clin Sleep Med"},{"key":"2023041906225982500_bib77","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/WNF.0b013e3182087d48","article-title":"A 52-week study of gabapentin enacarbil in restless legs syndrome","volume":"34","author":"Ellenbogen","year":"2011","journal-title":"Clin Neuropharmacol"},{"key":"2023041906225982500_bib78","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.sleep.2010.03.003","article-title":"A randomized, double-blind, 6-week, dose-ranging study of pregabalin in patients with restless legs syndrome","volume":"11","author":"Allen","year":"2010","journal-title":"Sleep Med"},{"key":"2023041906225982500_bib79","first-page":"e87","article-title":"Long-term efficacy and augmentation assessment of a dopamine agonist (pramipexole) compared with an alpha-2-delta ligand (pregabalin) in restless legs syndrome: results of a randomized, double\u2013blinded, placebo\u2013controlled trial","volume":"79","author":"Garcia-Borreguero","year":"2012","journal-title":"Emerg Sci Abstr Neurol"},{"key":"2023041906225982500_bib80","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.sleep.2008.11.003","article-title":"Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: a randomized, double-blind, placebo-controlled study","volume":"10","author":"Wang","year":"2009","journal-title":"Sleep Med"},{"key":"2023041906225982500_bib81","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.sleep.2007.12.006","article-title":"A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome","volume":"10","author":"Earley","year":"2009","journal-title":"Sleep Med"},{"key":"2023041906225982500_bib82","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/mds.22562","article-title":"A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome","volume":"24","author":"Grote","year":"2009","journal-title":"Mov Disord"},{"key":"2023041906225982500_bib83","first-page":"235","article-title":"Restless leg syndrome","volume":"78","author":"Bayard","year":"2008","journal-title":"Am Fam Physician"},{"key":"2023041906225982500_bib84","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1136\/bmj.297.6656.1101-a","article-title":"Restless leg syndrome in pregnancy","volume":"297","author":"Goodman","year":"1988","journal-title":"BMJ"},{"key":"2023041906225982500_bib85","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.sleep.2005.01.008","article-title":"Repeated IV doses of Iron provides effective supplemental treatment of restless leg syndrome","volume":"4","author":"Earley","year":"2005","journal-title":"Sleep Med"},{"key":"2023041906225982500_bib86","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.sleep.2004.01.013","article-title":"Pregnancy as a risk factor for restless legs syndrome","volume":"5","author":"Manconi","year":"2004","journal-title":"Sleep Med"},{"key":"2023041906225982500_bib87","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/mds.20148","article-title":"Pramipexole-treated Parkinson's disease during pregnancy","volume":"19","author":"Mucchiut","year":"2004","journal-title":"Mov Disord"},{"key":"2023041906225982500_bib88","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/mds.20560","article-title":"Pregnancy in Parkinson's disease: unique case report and review of the literature","volume":"20","author":"Scott","year":"2005","journal-title":"Mov Disord"},{"key":"2023041906225982500_bib89","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/mds.1214","article-title":"Long-term follow-up on restless legs syndrome patients treated with opioids","volume":"16","author":"Walters","year":"2001","journal-title":"Mov Disord"},{"key":"2023041906225982500_bib90","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/bmj.317.7162.839","article-title":"Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies","volume":"317","author":"Dolovich","year":"1998","journal-title":"BMJ"},{"key":"2023041906225982500_bib91","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0924-977X(01)00080-3","article-title":"Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD): acute placebo-controlled sleep laboratory studies with clonazepam","volume":"11","author":"Saletu","year":"2001","journal-title":"Eur Neuropsychopharmacol"},{"key":"2023041906225982500_bib92","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/bmj.288.6415.444","article-title":"Treatment of the restless legs syndrome with carbamazepine: a double blind study","volume":"288","author":"Telstad","year":"1984","journal-title":"BMJ"},{"key":"2023041906225982500_bib93","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1525-5050(03)00110-0","article-title":"Gabapentin exposure in human pregnancy: results from the Gabapentin Pregnancy Registry","volume":"4","author":"Montouris","year":"2003","journal-title":"Epilepsy Behav"},{"key":"2023041906225982500_bib94","first-page":"1222","article-title":"A comparative study of idiopathic and secondary restless legs syndrome in pregnancy [abstract]","volume":"27","author":"Miri","year":"2012","journal-title":"Mov Disord"},{"key":"2023041906225982500_bib95","first-page":"368","article-title":"Restless legs syndrome in patients on hemodialysis","volume":"22","author":"Saudi","year":"2011","journal-title":"Kidney Dis Transpl"},{"key":"2023041906225982500_bib96","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.ajkd.2004.01.007","article-title":"Restless legs syndrome in patients on dialysis","volume":"43","author":"Kavanagh","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"2023041906225982500_bib97","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1053\/ajkd.2001.25202","article-title":"A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients","volume":"38","author":"Thorpe","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"2023041906225982500_bib98","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/mds.22410","article-title":"Factors contributing to the development of restless legs syndrome in patients with Parkinson disease","volume":"24","author":"Lee","year":"2009","journal-title":"Mov Disord"},{"key":"2023041906225982500_bib99","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1002\/mds.22694","article-title":"Restless legs syndrome in Parkinson's disease","volume":"24","author":"Peralta","year":"2009","journal-title":"Mov Disord"},{"key":"2023041906225982500_bib100","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1524-4725.1995.tb00183.x","article-title":"The effect of sclerotherapy on restless legs syndrome","volume":"21","author":"Kanter","year":"1995","journal-title":"Dermatol Surg"},{"key":"2023041906225982500_bib101","first-page":"244","article-title":"Meta-analysis of hydroxyethylrutosides in the treatment of chronic venous insufficiency","volume":"23","author":"Poynard","year":"1994","journal-title":"Vasa"},{"key":"2023041906225982500_bib102","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.sleep.2007.04.022","article-title":"Impact of restless legs syndrome and iron deficiency on attention-deficit\/hyperactivity disorder in children","volume":"8","author":"Konofal","year":"2007","journal-title":"Sleep Med"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/89\/1053\/402\/50017311\/postgradmedj-89-402.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/89\/1053\/402\/50017311\/postgradmedj-89-402.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T06:26:47Z","timestamp":1681885607000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/89\/1053\/402\/6987472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,22]]},"references-count":102,"journal-issue":{"issue":"1053","published-online":{"date-parts":[[2013,3,22]]},"published-print":{"date-parts":[[2013,7,1]]}},"URL":"https:\/\/doi.org\/10.1136\/postgradmedj-2012-131634","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,7]]},"published":{"date-parts":[[2013,3,22]]}}}